Joint Formulary & PAD

Budesonide (Easyhaler Budesonide) - Asthma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Inhaler (dry powder)
Associated Icons :
Restrictions / Comments :
Important

Licensed in children.

PAD Profile

ChemicalSubstance :
Budesonide (Easyhaler Budesonide)
Indication :
Asthma
Group Name :
ICS
Keywords :
ICS, inhaled corticosteroids, respiratory, asthmatics
Brand Names Include :
Easyhaler Budesonide
Important Information :

Children only - ICS alone not recommended in adults with asthma.

DPI licensed in children, cost effective.

Prescribe by BRAND.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Budesonide (Easyhaler Budesonide) is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Asthma.

Committee Recommendations (1)

Budesonide Easyhaler may be considered in patients aged 12-17 if these other preferred, licensed devices are not suitable:

Clenil Modulite (beclometasone MDI) plus spacer (Volumatic, Able Spacer, Optichamber) or Qvar (beclometasone MDI) plus spacer (Aerochamber plus, Able Spacer, Optichamber) are the locally agreed preferred ICS devices.

If a breath activated device is necessary, consider:
Easyhaler Beclometasone (breath activated) DPI
Qvar Easi-Breathe (breath activated) MDI

Prescribe inhaler devices by BRAND to ensure consistency and avoid confusion

The guidelines for asthma can be found below